Statistics for Omega Therapeutics, (id:8067 OMGA)

Valuation metrics

Market cap

43.52M

Enterprise value

126.79M

Trailing P/E (ttm)

-0.44

Forward P/E

-0.86

PEG ratio

-0.86

Price/Sales (ttm)

6.89

Price/Book (mrq)

0.75

Enterprise Value/Revenue

20.08

Enterprise Value/EBITDA

-1.61

Overview

Shares outstanding

55.37M

Float

21.33M

Shares short

6.36M

% Held by insiders

0.02%

% Held by institutions

0.90%

Average volume (10 days)

409.71K

Average volume (90 days)

Price summary

52-Week low

0.75

52-Week high

6.30

52-Week change

-137.91%

Beta

1.84

50-Day moving average

1.14

200-Day moving average

2.13

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-776.94%

Operational effectiveness

Return on assets

-25.37%

Return on equity

-129.15%

Income statement

Revenue (ttm)

0.11

Revenue per share (ttm)

0.11

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-78,886,000.00

Net income to common (ttm)

-78,896,000.00

Diluted EPS (ttm)

-1.32

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

45.85M

Total cash per share (mrq)

0.83

Total debt (mrq)

126.95M

Total Debt/Equity (mrq)

483.39

Current ratio (mrq)

219.50%

Book value per share (mrq)

1.05

Cash flow

Cash flow statement

-64,604,000.00

Levered free cash flow (LFCF)

-41,808,876.00